Orphan drug regulations Country : Canada PDF

Save (0)
Close

Recommended

Description

Orphan drug regulations
Country : Canada

 

No orphan drug policy

 

i. Emergency drug release program/investigational new drugs (EDRP/IND) provides access to
unapproved drugs.

 

ii. SR and ED [scientific research (SR) and experimental develop ment (ED)] tax incentive program would
support R and D in the area of orphan drugs.

 

iii. Provision for reduction of fees for small market drugs under cost recovery.

 

iv. Process patents granted for biotechnology products

 

Country :US

Orphan drug act (January 4, 1983)

 

i. Designation granted based on prevalence of disease in the population of less than 200,000 people
(approximately 0.1%) or no reasonable expectation of profitability

 

ii. Protocol assistance to design research protocols

iii. Tax credits for clinical research

iv. Market exclusivity

v. Funding grants for clinical research to support development vi. Penalty for intentionally false
statement of orphan status

 

vii. Parallel track program and treatment INDs provide access to unapproved drugs

 

viii. Process patents granted for biotechnology products accelerated approvals

www.DuloMix.com

 

 

 

www.DuloMix.com